Triptolide sensitizes TRAIL-induced apoptosis in prostate cancer cells via p53-mediated DR5 up-regulation |
| |
Authors: | Hu Xiaowen Sun Yi |
| |
Affiliation: | Department of Pharmacy, Cancer Hospital, Fudan University, Shanghai 200032, China. |
| |
Abstract: | Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising agent for cancer therapy. However, a number of prostate cancer cells exhibit high resistance to TRAIL effect. In this study, we found that Triptolide, a Chinese medicine, significantly sensitizes prostate cancer cells to TRAIL-mediated cellular apoptosis by up-regulating DR5 expression. Triptolide treatment can suppress Akt/Hdm2 signaling pathway, and lead to p53 accumulation, thereby up-regulating DR5 expression. Taken together, all evidences indicate that Triptolide may become a promising therapeutic agent that prevents the progression of prostate cancer. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|